Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades 9 Meters Biopharma to Hold

Maxim Group Downgrades 9 Meters Biopharma to Hold

Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.

July 1, 2022

1 minute read

Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.

Benchmark Initiates Coverage On DPCM Capital with Buy Rating, Announces Price Target of $14

July 8, 6:15 AM

Benchmark analyst David Williams initiates coverage on DPCM Capital (NYSE:XPOA) with a Buy rating and announces Price Target of $14.

November 10, 5:20 AM

Keybanc analyst Justin Patterson maintains TechTarget (NASDAQ:TTGT) with a Overweight and lowers the price target from $70 to $60.

June 13, 8:09 AM

Over the past 3 months, 5 analysts have published their opinion on BRP (NASDAQ:DOOO) stock. These analysts are…

June 30, 12:00 PM

Over the past 3 months, 10 analysts have published their opinion on C.H. Robinson Worldwide (NASDAQ:CHRW) stock. These…